Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00199_DB01558_nanopub.RARi88COsp88v36gr01tHCIc-pl26frJZ433Rifl-tSwA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00199_DB01558 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00199_DB01558 label "DDI between Erythromycin and Bromazepam - Erythromcyin may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if erythromycin is initiated, discontinued or dose changed. Dosage adjustments may be required. [drugbank_resource:DB00199_DB01558]" assertion.
- drugbank_resource:DB00199_DB01558 identifier "drugbank_resource:DB00199_DB01558" assertion.
- drugbank_resource:DB00199_DB01558 title "DDI between Erythromycin and Bromazepam - Erythromcyin may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if erythromycin is initiated, discontinued or dose changed. Dosage adjustments may be required." assertion.
- drugbank:DB00199 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB01558 assertion.
- drugbank:DB01558 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB01558 assertion.